Feature | June 07, 2007

Should ‘bleeding-edge’ medical devices take a back seat to EHRs?

Efficiency is intelligent laziness.

Sometimes people can say the darndest things – even if they’re highly educated, nationally renowned and controversial thought leaders blessed by the likes of Warren Buffett.
Maggie Mahar, author of the book “Money-Driven Medicine,” and “Bull! A History of the Boom, 1982-1999,” (which Buffett apparently recommended in Berkshire Hathaway’s annual report), was scheduled to give a keynote address at the TEPR 2007: Towards the Electronic Patient Record conference in Dallas in late May. The catchy and curious titles of her books allude to her point of view about what’s wrong with healthcare today.
In a press release promoting her keynote, TEPR publishes the following direct and indirect quotes attributed to Mahar. “At this point,” she warns, “there is a real danger that investments in bleeding-edge medical technologies will crowd out investment in healthcare IT. A drive for short-term profits has curtailed investments in HIT which could, in the long run, reduce errors and contain costs.” [Mahar] also points to startling new evidence that suggests that one out of every three of our healthcare dollars is squandered on unnecessary or redundant tests; unproven, sometimes unwanted procedures; and overpriced drugs and devices that, too often, are no better than the less expensive products they have replaced. “To combat waste, healthcare providers need electronic medical records,” says Mahar. “Those records could provide the database that we desperately need to compare the effectiveness of various treatments. It’s too labor-intensive – and too expensive – to try to make those comparisons while working with paper records.”
Much of her point of view in these quotes isn’t earth-shattering rocket science. EHRs have been discussed and dissected for at least the past five years with similar conclusions prevailing. What brings pause is Mahar’s implication that healthcare facilities should shift some of their investment in “bleeding-edge” medical technology to IT for a variety of reasons. Unfortunately, the negativity she applies to medical technology – including drugs – may also be attached to IT.
1. IT is all about short-term profits. Mahar must have mind-blocked the greed-infected dot-com mania between 1998 and 2001 in healthcare. Obviously, none of the companies in the EHR/EMR business today is motivated by profit. Unlike drugs and high-end medical devices and tests, apparently EHR software is priced competitively and reasonably by comparison, particularly if you factor in the overall return-on-investment.
2. Overpriced drugs and medical devices obviously don’t help patients heal faster, thereby reducing long-term healthcare costs all around. Any long-term gains must be overshadowed by short-term profits.
3. Whether products (including procedures and tests) are unnecessary, redundant, unproven, unwanted or even “no better than the less expensive products they have replaced” is highly subjective at best, regardless of the studies that allegedly “prove” it. Enough studies and surveys have been conducted within the last few years that illuminate the fissures between the IT adopters/implementers and the risk-averse procrastinators.
The bottom line for the skeptics is that the EHR movement followed too closely on the heels of the dot-com “revolution,” which arrived on the heels of the “Y2K” fad.
While the efficiency contributions of EHRs are not in doubt, you have to recognize who really benefits from the adoption and implementation. Providers and patients stand to reap considerable rewards. Obviously, the vendors will, too. But EHRs replace mountains of paperwork for the payers. Yet among the din of providers complaining about the total costs of EHR investment and the government granting safe harbors to vendors for “giveaways” and related support, not a peep nor any provision emanates from the payers who stand to gain the most. How transparent.

Related Content

AI Visualize Inc. Debuts Artificial Intelligence Cloud Image Visualization Platform at RSNA 2017
Technology | Remote Viewing Systems | December 13, 2017
AI Visualize Inc. debuted its new cloud-based artificial intelligence (A.I.) -based image analysis and viewing platform...
Ambra Health Rolls Out New Features for Medical Image Exchange Platform
News | Vendor Neutral Archive (VNA) | November 20, 2017
Ambra Health announced that Atrius Health and Envision Radiology are among the latest leading providers to adopt Ambra...
Intelerad Unveils Imaging Infrastructure-as-a-Service Platform
Technology | PACS Accessories | November 07, 2017
November 7, 2017 — Intelerad Medical Systems recently announced the expansion of its cloud-based solution suite.
News | Enterprise Imaging | November 03, 2017
November 3, 2017 — Mach7 Technologies invites attendees at the 2017 Radiological Society of North America (RSNA) annu
Frost & Sullivan Research Highlights Benefits of Intelerad's CosmosOne
News | Vendor Neutral Archive (VNA) | October 23, 2017
October 23, 2017 — Intelerad Medical Systems has been highlighted for its innovative approach to...
Fujifilm Launches Synapse VNA Version 6.4 With Additional DICOM Web Support
Technology | Archive Cloud Storage | September 08, 2017
September 8, 2017 — Fujifilm Medical Systems U.S.A. Inc.
Fujifilm Brings Synapse Enterprise Imaging Solutions to Seven Healthcare Systems
News | Enterprise Imaging | August 31, 2017
Fujifilm Medical Systems U.S.A. Inc. was recently designated the enterprise imaging partner of choice for several...
Rayence Launches New Cloud PACS Product Across South Carolina IDN
News | PACS | August 28, 2017
August 28, 2017 — Rayence Inc.
Technology | Archive Cloud Storage | May 26, 2017
Intelerad Medical Systems launched CosmosOne, a living medical archive that centralizes all types of patient health...
Overlay Init